Riskpilot← Back to searchSign inGet full accessCS Naprapati & Hälsa AB
ABActiveOrg 5592593205Valhallavägen 13Physiotherapy activities · NACE 8695Est. 20200 employees
Revenue 2025
SEK 965K
-1% vs 2024
EBITDA margin
8.3%
-1% vs 2024
Equity ratio
90.7%
Financial strength
Net profit 2025
SEK 61K
-9% vs 2024
| Revenue | SEK 965K | -1% |
| EBITDA | SEK 80K | -1% |
| Net profit | SEK 61K | -9% |
| Total assets | SEK 318K | -7% |
| Equity | SEK 288K | -8% |
| Employees | 0 | — |
Legal name
CS Naprapati & Hälsa AB
Org number
5592593205
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
11 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall i huvudsak bedriva verksamhet som innefattar naprapatbehandlingar samt eventuellt även föreläsningar och konsultuppdrag inom naprapati och hälsa.
Address
Valhallavägen 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 880 | 859 | 923 | 977 | 965 |
| Staff expenses | — | −514 | −522 | −566 | −565 |
| EBITDA | 164 | −19 | 80 | 81 | 80 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 164 | −19 | 80 | 81 | 80 |
| Net financials | — | −0 | 0 | 4 | 0 |
| Profit before tax | 165 | −20 | 80 | 85 | 80 |
| Tax | −36 | — | −15 | −18 | −19 |
| Net profit | 129 | −20 | 65 | 67 | 61 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 310 | 326 | 300 | 342 | 318 |
| Equity | 251 | 232 | 247 | 314 | 288 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 59 | 95 | 53 | 27 | 30 |
| Total debt | 59 | 95 | 53 | 27 | 30 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20212025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20212025
Return on equity
21.3%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
6.4%
This company
8.1%
Market median
-21% vs market
20212025
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CS Naprapati & Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Christian Strömberg | Board of Directors | 0 companies |
| Roy Bertil Christer Strömberg | Deputy Board Member | 0 companies |